甘精胰岛素联合那格列奈对糖尿病肾病老年患者血糖控制及肾功能的影响被引量：1

导出

摘要目的研究甘精胰岛素联合那格列奈对糖尿病肾病(DN)老年患者血糖控制及肾功能的影响。方法按照随机数字表法将106例DN老年患者分为两组,各53例。对照组采用甘精胰岛素治疗,观察组采用甘精胰岛素联合那格列奈治疗。治疗3个月后,对比两组治疗前后血糖指标变化、肾功能指标及低血糖发生率。结果观察组2hPG、FPG、BUN、SCr低于对照组,差异有统计学意义(P<0.05);观察组低血糖发生率3.77%,低于对照组18.87%,差异有统计学意义(P<0.05)。结论甘精胰岛素联合那格列奈治疗老年DN,可降低血糖值、改善肾功能,降低低血糖发生率。

作者睢凤玲

机构地区河南省新郑市人民医院

出处《首都食品与医药》 2019年第14期98-98,共1页 Capital Food Medicine

关键词老年糖尿病肾病甘精胰岛素那格列奈肾功能

分类号 R587.2 [医药卫生—内分泌] R692.9 [医药卫生—内科学]

引文网络
相关文献

参考文献2

1庞敏.甘精胰岛素联合那格列奈治疗2型糖尿病疗效观察[J].徐州医学院学报,2014,34(6):391-394. 被引量：5
2青华,罗蓉,李启富.那格列奈和瑞格列奈改善2型糖尿病患者胰岛β细胞功能的比较研究[J].重庆医科大学学报,2005,30(3):390-393. 被引量：18

二级参考文献20

1Kahn SE, Verchere CB, Andrikopulos S, et al. Reduced anaylin release is a characteristis of impaired glucose tolerance and type 2 diabetes in Japancese Americans[ J ]. Diabetes, 1998,47(4) : 640 — 645. 被引量：1
2Uchino H, Niwa M, Shimizu T, et al. Impairment of early insulin response after glucose load, rather than insulin resistance,is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogue[ J ]. Endocr J ,2000,47(5) : 639 — 641. 被引量：1
3Bruce DG, Chisholm DJ, Storlien LH, et al. Physilolgical importance of deficiency in early prandial insulin secretion in non - dependent diabetes [ J ]. Diabetes, 1998,37 (6) : 736 — 744. 被引量：1
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients[ J ]. Diabetes, 1999, 48 ( 1 ) : 99 — 105. 被引量：1
5Hanefeld - M, Temelkova - Kurktschiev - T. Control of post - prandial hyperglycemia- an essential part of good diabetes treatment and prevention of cardiovascular complications [ J ].Nutr- Metab - Cardiovasc - Dis,2002,12(2) : 98 — 107. 被引量：1
6Bell - D - S. Importance of postprandial glucose control [ J ]. South - Med - J,2001,94(8) : 804 — 809. 被引量：1
7Odawara - M. Nateglinide and Mitiglinide[ J ]. Nippon - Rinsho, 2003 , 61 (7) : 1230 — 1237. 被引量：1
8Jyoti B,Kalbag,Jerry R,et al. Mealtime glucose regulation with mateglinide in healthy volunteers[ J ]. Diabetes care, 2001 ,24(1) : 73 — 77. 被引量：1
9Hr S, Wang S, Fanelli B, et al. Pancreatic β - cell KATP channel activity and membrane binding studies with nateglinide:a comparison with sulfonylureas and repaglinde[ J ]. J Pharmacol Exp Ther, 2000, 293 (2) : 444 — 452. 被引量：1
10Guardado-Mendoza R,Prioletta A,Jiménez-Ceja LM,et al.The role of nateglinide and repaglinide,derivatives of meglitinide,in the treatment of type 2 diabetes mellitus[J].Arch Med Sci,2013,9(5):936-943. 被引量：1